Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:investor
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
early-stage life sciences investments
|
| gptkbp:founded |
1980
|
| gptkbp:funds_raised |
over $3 billion
|
| gptkbp:headquarters_location |
gptkb:Cambridge,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Atlas Venture (US arm)
|
| gptkbp:industry |
gptkb:biotechnology
gptkb:insurance |
| gptkbp:investment_stage |
gptkb:Series_A
seed Early stage |
| gptkbp:managingPartner |
gptkb:Bruce_Booth
gptkb:Jason_Rhodes gptkb:Jean-François_Formela |
| gptkbp:notableExit |
gptkb:Alnylam_Pharmaceuticals_IPO
gptkb:Blueprint_Medicines_IPO gptkb:Editas_Medicine_IPO |
| gptkbp:notableInvestment |
gptkb:Alnylam_Pharmaceuticals
gptkb:Editas_Medicine gptkb:Replimune gptkb:Surface_Oncology gptkb:Blueprint_Medicines |
| gptkbp:separates |
Atlas Venture (European arm)
|
| gptkbp:spinOff |
Atlas Venture (original global firm)
|
| gptkbp:website |
https://www.atlasventure.com/
|
| gptkbp:bfsParent |
gptkb:Accomplice_VC
|
| gptkbp:bfsLayer |
8
|